Skip to main content
Erschienen in: Drugs & Aging 10/2013

01.10.2013 | Systematic Review

Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals

verfasst von: Luwam Ghidei, Mark J. Simone, Marci J. Salow, Kristin M. Zimmerman, Allison M. Paquin, Lara M. Skarf, Tia R. M. Kostas, James L. Rudolph

Erschienen in: Drugs & Aging | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Older adults are generally considered to be at greater risk for medication non-adherence due to factors such as medication complexity, side effects, cost, and cognitive decline. However, this generalization may not apply to older adults with human immunodeficiency virus (HIV). Regardless of age, suboptimal adherence to antiretroviral therapy (ART) can lead to increased viral load, immunosuppression, drug-resistant viral strains, co-morbidities, and opportunistic infections. Understanding trends of adherence to ART among older adults is critical, especially as the population of people living with HIV grows older.

Objectives

The purpose of this systematic review and meta-analysis is to determine if older individuals with HIV are less likely to be non-adherent to antiretroviral therapy than younger individuals with HIV.

Design

A systematic search in PubMed, Embase, and PsycINFO was conducted to identify peer-reviewed articles evaluating adherence to ART in older adults. Two independent reviewers screened abstracts, applied inclusion criteria, and appraised study quality. The bibliographies of qualifying studies were searched. Data were abstracted from studies by two independent authors. Meta-analyses were conducted, and adherence levels were reported as the relative risk of non-adherence in older individuals compared to younger individuals.

Results

The systematic search yielded 1,848 abstracts. Twelve studies met full inclusion criteria. The overall meta-analysis found that older age reduced risk for non-adherence by 27 % (relative risk (RR) 0.72, 95 % confidence interval (CI) 0.64–0.82). Studies assessing both short-term and long-term adherence demonstrated a significant reduction in non-adherence among older patients (RR 0.75, 95 % CI 0.64–0.87 and RR 0.65, 95 % CI 0.50–0.85, respectively).

Conclusions

Older adults with HIV have a reduced risk for non-adherence to ART than their younger counterparts. Future studies should seek to elucidate contributing factors of adherence among older individuals with HIV.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;2012(102):1516–26.CrossRef Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;2012(102):1516–26.CrossRef
5.
Zurück zum Zitat Collaboration TATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef Collaboration TATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef
6.
Zurück zum Zitat Abrass CK, Appelbaum JS, Boyd CM, Braithwaite RS, Broudy VC, Covinsky K, et al. HIV and aging consensus project; recommended treatment strategies for clinicians managing older patients with HIV. J Am Geriatr Soc. 2012;60:974–9.CrossRef Abrass CK, Appelbaum JS, Boyd CM, Braithwaite RS, Broudy VC, Covinsky K, et al. HIV and aging consensus project; recommended treatment strategies for clinicians managing older patients with HIV. J Am Geriatr Soc. 2012;60:974–9.CrossRef
7.
Zurück zum Zitat Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedCrossRef Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedCrossRef
8.
Zurück zum Zitat Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3:453–72.PubMed Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3:453–72.PubMed
9.
Zurück zum Zitat Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261–8.PubMedCrossRef Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261–8.PubMedCrossRef
10.
Zurück zum Zitat Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretroviral in HIV-infected patients. HIV Clin Trials. 2002;3:371–8.PubMedCrossRef Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, et al. Simpler regimens may enhance adherence to antiretroviral in HIV-infected patients. HIV Clin Trials. 2002;3:371–8.PubMedCrossRef
11.
Zurück zum Zitat Dunham PJ, Karkula JM. Effects of a pharmacy-care program on adherence and outcomes. Am J Pharm Benefits. 2012;4:e8–14. Dunham PJ, Karkula JM. Effects of a pharmacy-care program on adherence and outcomes. Am J Pharm Benefits. 2012;4:e8–14.
12.
Zurück zum Zitat Viswanathan H, Anderson R, Thomas Iii J. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care STDS. 2005;19:306–16.PubMedCrossRef Viswanathan H, Anderson R, Thomas Iii J. Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. AIDS Patient Care STDS. 2005;19:306–16.PubMedCrossRef
13.
Zurück zum Zitat Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract. 2008;22:114–47.PubMedCrossRef Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract. 2008;22:114–47.PubMedCrossRef
14.
Zurück zum Zitat Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17:645–56.PubMedCrossRef Johnson MO, Catz SL, Remien RH, Rotheram-Borus MJ, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the healthy living project. AIDS Patient Care STDS. 2003;17:645–56.PubMedCrossRef
15.
Zurück zum Zitat Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992–2004). J Acquir Immune Defic Syndr. 2007;44:20–9.PubMedCrossRef Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992–2004). J Acquir Immune Defic Syndr. 2007;44:20–9.PubMedCrossRef
16.
Zurück zum Zitat Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.PubMedCrossRef Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Marion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–9.PubMedCrossRef
17.
Zurück zum Zitat Cuzin L, Delpierre C, Gerard Sp, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged 150 years. Clin Infect Dis. 2007;45:654–7.PubMedCrossRef Cuzin L, Delpierre C, Gerard Sp, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged 150 years. Clin Infect Dis. 2007;45:654–7.PubMedCrossRef
18.
Zurück zum Zitat Sherr L, Harding R, Lampe F, Johnson M, Anderson J, Zetler S, et al. Clinical and behavioural aspects of aging with HIV infection. Psychol Health Med. 2009;14:273–9.PubMedCrossRef Sherr L, Harding R, Lampe F, Johnson M, Anderson J, Zetler S, et al. Clinical and behavioural aspects of aging with HIV infection. Psychol Health Med. 2009;14:273–9.PubMedCrossRef
19.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef
20.
Zurück zum Zitat Elema R, Mills C, Yun O, Lokuge K, Ssonko C, Nyirongo N, et al. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. J Int Assoc Physicians AIDS Care (Chic). 2009;8:60–7.CrossRef Elema R, Mills C, Yun O, Lokuge K, Ssonko C, Nyirongo N, et al. Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007. J Int Assoc Physicians AIDS Care (Chic). 2009;8:60–7.CrossRef
21.
Zurück zum Zitat Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. HIV Med. 2013 (Epub ahead of print). Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review. HIV Med. 2013 (Epub ahead of print).
22.
Zurück zum Zitat Mills EJ, Nachega JB, Buchan I, Orbinski J, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef Mills EJ, Nachega JB, Buchan I, Orbinski J, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef
24.
Zurück zum Zitat Higgins J. Heterogeneity in meta-analyses should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMedCrossRef Higgins J. Heterogeneity in meta-analyses should be expected and appropriately quantified. Int J Epidemiol. 2008;37:1158–60.PubMedCrossRef
25.
Zurück zum Zitat Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2008. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata™. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2008.
26.
Zurück zum Zitat Lyimo R, van den Boogarden J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:1–20.CrossRef Lyimo R, van den Boogarden J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. BMC Public Health. 2011;11:1–20.CrossRef
27.
Zurück zum Zitat Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601–11.PubMedCrossRef Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601–11.PubMedCrossRef
28.
Zurück zum Zitat Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19–25.PubMedCrossRef Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:S19–25.PubMedCrossRef
29.
Zurück zum Zitat Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684–91.PubMedCrossRef Silverberg MJ, Leyden W, Horberg MA, et al. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167:684–91.PubMedCrossRef
30.
Zurück zum Zitat Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939–45.PubMedCrossRef Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939–45.PubMedCrossRef
31.
Zurück zum Zitat Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63:6–12.PubMed Simone MJ, Appelbaum J. HIV in older adults. Geriatrics. 2008;63:6–12.PubMed
32.
Zurück zum Zitat Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82–92.PubMed Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82–92.PubMed
33.
Zurück zum Zitat Dowshen N, D’Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762–71.PubMedCrossRef Dowshen N, D’Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762–71.PubMedCrossRef
34.
Zurück zum Zitat Greene M, Justice AC, Valcour V, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397–405.PubMedCrossRef Greene M, Justice AC, Valcour V, et al. Management of human immunodeficiency virus infection in advanced age. JAMA. 2013;309:1397–405.PubMedCrossRef
35.
36.
Zurück zum Zitat Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1–18.CrossRef Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60:S1–18.CrossRef
37.
Zurück zum Zitat Johnson CJ, Heckman TG, Hansen NB, et al. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care Psychol Soc Med Aspects AIDS/HIV. 2009;21(5):541–51.CrossRef Johnson CJ, Heckman TG, Hansen NB, et al. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care Psychol Soc Med Aspects AIDS/HIV. 2009;21(5):541–51.CrossRef
38.
Zurück zum Zitat Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:1–32.CrossRef Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:1–32.CrossRef
39.
Zurück zum Zitat Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235–44.PubMedCrossRef Shah B, Walshe L, Saple DG, et al. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007;44:1235–44.PubMedCrossRef
40.
Zurück zum Zitat Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9:11–23.PubMedCrossRef Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9:11–23.PubMedCrossRef
41.
Zurück zum Zitat Ladefoged K, Andersson M, Koch A, et al. Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients. Int J Circumpolar Health. 2012;71:1–8. Ladefoged K, Andersson M, Koch A, et al. Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patients. Int J Circumpolar Health. 2012;71:1–8.
42.
Zurück zum Zitat Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15:1397–409.PubMedCrossRef Raboud J, Li M, Walmsley S, et al. Once daily dosing improves adherence to antiretroviral therapy. AIDS Behav. 2011;15:1397–409.PubMedCrossRef
43.
Zurück zum Zitat Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr. 2010;55:221–4.PubMedCrossRef Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr. 2010;55:221–4.PubMedCrossRef
44.
Zurück zum Zitat Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, et al. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002;35:1173–81.PubMedCrossRef Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, et al. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res. 2002;35:1173–81.PubMedCrossRef
45.
Zurück zum Zitat Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc. 2002;50:603–7.PubMedCrossRef Wellons MF, Sanders L, Edwards LJ, et al. HIV infection: treatment outcomes in older and younger adults. J Am Geriatr Soc. 2002;50:603–7.PubMedCrossRef
46.
Zurück zum Zitat Watt MH, Maman S, Golin CE, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22:381–9.PubMedCrossRef Watt MH, Maman S, Golin CE, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22:381–9.PubMedCrossRef
47.
Zurück zum Zitat Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve HIV patients. HIV Clin Trials. 2011;12:244–54.PubMedCrossRef Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve HIV patients. HIV Clin Trials. 2011;12:244–54.PubMedCrossRef
48.
Zurück zum Zitat Fletcher M, Brundage R, Chesney M, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. J Acquir Immune Defic Syndr. 2005;40:301–6.PubMedCrossRef Fletcher M, Brundage R, Chesney M, et al. Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. J Acquir Immune Defic Syndr. 2005;40:301–6.PubMedCrossRef
49.
Zurück zum Zitat Manfredi R, Chiodo F. A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14:1475–7.PubMedCrossRef Manfredi R, Chiodo F. A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS. 2000;14:1475–7.PubMedCrossRef
50.
Zurück zum Zitat Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185–94.PubMedCrossRef Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11:185–94.PubMedCrossRef
Metadaten
Titel
Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals
verfasst von
Luwam Ghidei
Mark J. Simone
Marci J. Salow
Kristin M. Zimmerman
Allison M. Paquin
Lara M. Skarf
Tia R. M. Kostas
James L. Rudolph
Publikationsdatum
01.10.2013
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 10/2013
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-013-0107-7

Weitere Artikel der Ausgabe 10/2013

Drugs & Aging 10/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.